<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(2)</volume><submitter>Zhang C</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To explore the utility of deep brain stimulation (DBS) telemedicine in the management of patients with movement disorders from January 2019 to March 2020, covering the main period of the COVID-19 outbreak in China.&lt;h4>Materials and methods&lt;/h4>We obtained data from 40 hospitals around China that employed DBS tele-programming for their outpatients with Parkinson's disease or dystonia from January 2019 to March 2020. Data were obtained on the number and nature of patients' DBS health care service requests, reasons for their requests, the number of DBS telemedicine sessions subsequently completed, safety issues, and the patients' satisfaction with the DBS tele-programing parameter adjustments made.&lt;h4>Results&lt;/h4>There were 909 DBS tele-programming health service requests (f</pubmed_abstract><journal>Neuromodulation : journal of the International Neuromodulation Society</journal><pagination>337-342</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7646652</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Utility of Deep Brain Stimulation Telemedicine for Patients With Movement Disorders During the COVID-19 Outbreak in China.</pubmed_title><pmcid>PMC7646652</pmcid><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Sun B</pubmed_authors><pubmed_authors>Zhu K</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Huang P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Utility of Deep Brain Stimulation Telemedicine for Patients With Movement Disorders During the COVID-19 Outbreak in China.</name><description>&lt;h4>Objective&lt;/h4>To explore the utility of deep brain stimulation (DBS) telemedicine in the management of patients with movement disorders from January 2019 to March 2020, covering the main period of the COVID-19 outbreak in China.&lt;h4>Materials and methods&lt;/h4>We obtained data from 40 hospitals around China that employed DBS tele-programming for their outpatients with Parkinson's disease or dystonia from January 2019 to March 2020. Data were obtained on the number and nature of patients' DBS health care service requests, reasons for their requests, the number of DBS telemedicine sessions subsequently completed, safety issues, and the patients' satisfaction with the DBS tele-programing parameter adjustments made.&lt;h4>Results&lt;/h4>There were 909 DBS tele-programming health service requests (f</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-04T03:06:17.902Z</modification><creation>2020-11-09T08:48:19Z</creation></dates><accession>S-EPMC7646652</accession><cross_references><pubmed>33006811</pubmed><doi>10.1111/ner.13274</doi></cross_references></HashMap>